Prosecution Insights
Prosecution Insights
9 pending office actions • 7 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (11%) |
| §102 only | 3 (33%) |
| §112 only | 1 (11%) |
| Double-patenting only | 1 (11%) |
| Multi-statute (no §101) | 3 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, CHIHYI NMN | 1 | 32.9% | +58.5% |
| WILSON, JERICA KATLYNN | 1 | 61.5% | +38.7% |
| WILLIS, DOUGLAS M | 1 | 82.4% | +19.5% |
| INAM, SAHAR | 1 | 100.0% | +0.0% |
| SEITZ, ANTHONY JOSEPH | 1 | 67.7% | +28.1% |
| NOTTINGHAM, KYLE GREGORY | 1 | 59.4% | +34.6% |
| JOHANNSEN, DIANA B | 1 | 53.5% | +41.8% |
| XIAO, YAN | 1 | 67.8% | +51.6% |
| DAVIS, BRIAN J | 1 | 84.8% | -4.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18694848 | COMBINATIONS OF KRAS G12D INHIBITORS WITH PI3Ka INHIBITORS AND RELATED METHODS OF TREATMENT | WILLIS, DOUGLAS M | — |
| 18572110 | Aminopyridine-based MTA-Cooperative PRMT5 Inhibitors | INAM, SAHAR | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18286961 | KRAS G12C INHIBITORS | SEITZ, ANTHONY JOSEPH | 49d overdue |
| 18018422 | SOS1 INHIBITORS | DAVIS, BRIAN J | 4d overdue |
| 18274441 | COMBINATION THERAPIES | NOTTINGHAM, KYLE GREGORY | 12d |
| 18697932 | COMBINATION THERAPIES USING PRMT5 INHIBITORS FOR THE TREATMENT OF CANCER | WILSON, JERICA KATLYNN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18286961 | KRAS G12C INHIBITORS | SEITZ, ANTHONY JOSEPH | 49d overdue |
| 18026799 | COMBINATION THERAPIES | XIAO, YAN | 7d |
| 18274441 | COMBINATION THERAPIES | NOTTINGHAM, KYLE GREGORY | 12d |
| 18032492 | METHODS FOR TREATMENT OF LUNG CANCERS | JOHANNSEN, DIANA B | 40d |
| 18658666 | Substituted Quinoxalines | LEE, CHIHYI NMN | — |
| 18697932 | COMBINATION THERAPIES USING PRMT5 INHIBITORS FOR THE TREATMENT OF CANCER | WILSON, JERICA KATLYNN | — |
| 18694848 | COMBINATIONS OF KRAS G12D INHIBITORS WITH PI3Ka INHIBITORS AND RELATED METHODS OF TREATMENT | WILLIS, DOUGLAS M | — |
| Art Unit | Apps |
|---|---|
| 1621 | 2 |
| 1624 | 1 |
| 1622 | 1 |
| 1629 | 1 |
| 1682 | 1 |
| 1642 | 1 |
| 1614 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18658666 | Substituted Quinoxalines | LEE, CHIHYI NMN | — | DP | Non-Final OA | — | Pending | May 08, 2024 |
| 18697932 | COMBINATION THERAPIES USING PRMT5 INHIBITORS FOR THE TREATMENT OF CANCER | WILSON, JERICA KATLYNN | 1621 | §103§112 | Non-Final OA | — | Pending | Apr 02, 2024 |
| 18694848 | COMBINATIONS OF KRAS G12D INHIBITORS WITH PI3Ka INHIBITORS AND RELATED METHODS OF TREATMENT | WILLIS, DOUGLAS M | 1624 | §112 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18572110 | Aminopyridine-based MTA-Cooperative PRMT5 Inhibitors | INAM, SAHAR | 1622 | §102 | Non-Final OA | — | Pending | Dec 19, 2023 |
| 18286961 | KRAS G12C INHIBITORS | SEITZ, ANTHONY JOSEPH | 1629 | §101DP | Final Rejection | 49d overdue | Pending | Oct 13, 2023 |
| 18274441 | COMBINATION THERAPIES | NOTTINGHAM, KYLE GREGORY | 1621 | §102§103§112Other | Non-Final OA | 12d | Pending | Jul 26, 2023 |
| 18032492 | METHODS FOR TREATMENT OF LUNG CANCERS | JOHANNSEN, DIANA B | 1682 | §102 | Final Rejection | 40d | Pending | Apr 18, 2023 |
| 18026799 | COMBINATION THERAPIES | XIAO, YAN | 1642 | §102 | Non-Final OA | 7d | Pending | Mar 16, 2023 |
| 18018422 | SOS1 INHIBITORS | DAVIS, BRIAN J | 1614 | §102§112 | Non-Final OA | 4d overdue | Pending | Jan 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial